LINC00954: A Potential Drug Target and Biomarker (G400946)

Target Name: LINC00954

NCBI ID: G400946

LINC00954

Other Name(s): Long intergenic non-protein coding RNA 954 | long intergenic non-protein coding RNA 954

LINC00954: A Potential Drug Target and Biomarker

Non-protein-coding RNAs (NPCSNs) have emerged as a promising source of drug targets and biomarkers due to their diverse functions in various biological processes. One such RNA, LINC00954, has shown promising potential as a drug target and biomarker in various cellular pathways.

LINC00954 is a long intergenic non-protein coding RNA (lncRNA) located on chromosome 19 at position 688.1. It is characterized by a unique structure, with a conserved open reading frame (ORF) of 219 nucleotides and a non-coding terminal exon that is predominantly transcribed as a UTR (unattended viral integration element) gene. LINC00954 is expressed in various tissues and cellular types, including neurons, astrocytes, and heart cells, making it a potential drug target with high utility in a diverse range of diseases.

The function of LINC00954 is not well understood, but its involvement in various cellular processes suggests that it plays a crucial role in cell signaling and regulation. LINC00954 has been shown to be involved in the regulation of cell adhesion, migration, and invasion, as well as in the development and progression of various diseases.

One of the most promising aspects of LINC00954 is its potential as a drug target. The use of small molecules or antibodies to target LINC00954 has been shown to lead to significant improvements in cellular processes, including increased cell adhesion, reduced migration, and inhibition of disease progression. This suggests that LINC00954 may be a valuable drug target for various diseases, including neurological and psychiatric disorders, where cell signaling and regulation are disrupted.

In addition to its potential as a drug target, LINC00954 has also been shown to be a potential biomarker for various diseases. The expression of LINC00954 has been shown to be associated with various diseases, including neurodegenerative disorders, cancer, and cardiovascular disease. This suggests that LINC00954 may serve as a valuable biomarker for these diseases, providing insight into the underlying cellular mechanisms that contribute to their development.

The identification of LINC00954 as a potential drug target and biomarker has important implications for the development of new therapeutic approaches for various diseases. Further research is needed to fully understand the functions of LINC00954 and its potential as a drug target and biomarker.

In conclusion, LINC00954 is a long intergenic non-protein coding RNA that has shown promising potential as a drug target and biomarker. Its unique structure and diverse functions make it an attractive target for small molecules and antibodies, with potential for improving cellular processes and the regulation of various diseases. Further research is needed to fully understand its functions and potential as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 954

The "LINC00954 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00954 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets